Status:
COMPLETED
Bacterial Translocation Markers as Predictors of Infectious and Inflammatory Complications in Acute Bowel Obstruction
Lead Sponsor:
Karaganda Medical University
Collaborating Sponsors:
Ministry of Education and Science, Republic of Kazakhstan
Conditions:
Intestinal Obstruction
Colorectal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Despite modern approaches to the diagnosis and treatment of acute bowel obstruction (ABO), postoperative mortality ranges from 5 to 32%, and complications occur up 23% of cases. One of the formidable ...
Detailed Description
For the early diagnosis of infectious and inflammatory complications, it is necessary to study LBP, sCD-14 and 16sRNA as bacterial translocation markers in patients with malignant and benign acute bow...
Eligibility Criteria
Inclusion
- patients with malignant acute bowel obstruction,
- patients with benign acute bowel obstruction,
- colorectal cancer patients without acute bowel obstruction (planned operations).
Exclusion
- age less than 18,
- pregnancy,
- patients with paralytic acute bowel obstruction,
- patients with HIV infection, liver cirrhosis,
- patient with an infectious process due to another pathology.
Key Trial Info
Start Date :
March 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05229822
Start Date
March 1 2021
End Date
December 31 2023
Last Update
January 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NJSC Karaganda Medical University
Karaganda, Kazakhstan, 100000